Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:01 AM
Ignite Modification Date: 2025-12-25 @ 12:01 AM
NCT ID: NCT04749758
Eligibility Criteria: Inclusion Criteria: Male and female over 18 years of age patients affected from unilateral or bilateral symptomatic knee osteoarthritis (KOA), determined by the diagnostic criteria of the American College of Rheumatology. Any degree of the Kellgren and Lawrence classification for KOA is included. Patients included must have KOA symptoms more than 6 months. Symptomatology must remain despite having done conventional treatment for KOA. Exclusion Criteria: * Suspicion, diagnosis or history of active or recent joint infection (less than 6 months) * Neurological deficit in the affected limb * Pregnant or breastfeeding women * Positive serology for hepatitis B, hepatitis C and / or HIV * Magnetic resonance imaging without pathological alterations * Knee infiltration with glucocorticoids, hyaluronic acid, platelet - rich plasma and / or other regenerative medicine therapies in the last 3 months. * Medical conditions, including the diagnosis of oncological pathology or infectious and severe heart, kidney or liver disease, which contraindicate sedation or liposuction procedure. * History or diagnosis of dementia or higher functions unpreserved, which interfere communication. * Not having the necessary skills and / or electronic devices necessary (even their relatives or acquaintances, or they can not help them) to complete the online questionnaires.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT04749758
Study Brief:
Protocol Section: NCT04749758